echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > The Synthetic Routes of Pristinamycin

    The Synthetic Routes of Pristinamycin

    • Last Update: 2023-05-11
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Pristinamycin is an antibiotic drug that is used to treat various types of bacterial infections.


    It is a member of the streptogramin group of antibiotics, which are produced by a group of bacteria known as the Streptograminaceae.


    Pristinamycin has been used to treat a wide variety of bacterial infections, including respiratory tract infections, skin infections, and urinary tract infections.



    The synthesis of pristinamycin has been a subject of extensive research in the chemical industry.


    There are several synthetic routes that have been developed to produce pristinamycin, each with its own advantages and disadvantages.


    In this article, we will discuss some of the most common synthetic routes for pristinamycin and the chemical industry's efforts to improve their efficiency and yield.



    One of the most commonly used synthetic routes for pristinamycin is the Schlüsselreaction.


    This reaction involves the condensation of 3-dehydroquinatein, which is derived from Tryptophan, with 7-oxo-1,4-dihydroadamantane, resulting in the formation of an intermediate.


    This intermediate is then transformed into pristinamycin through a series of further reactions.


    This synthetic route has been found to be efficient and cost-effective, but it requires the use of several toxic reagents, which can make it hazardous to handle.



    Another synthetic route for pristinamycin involves the use of a Staudinger reaction.


    In this reaction, 2-chloro-1,3-oxazolidine is treated with a Grignard reagent, which is then transformed into pristinamycin through a series of further reactions.


    This route has been found to be less hazardous to handle than the Schlüsselreaction, but it requires the use of expensive reagents and greener alternatives are being sought.



    A more recent synthetic route for pristinamycin has been developed using a Suzuki-Miyaura cross-coupling reaction.


    In this reaction, iodoarene is treated with a boronic acid, resulting in the formation of an intermediate.


    This intermediate is then transformed into pristinamycin through a series of further reactions.


    This route has been found to be efficient and selective, but it requires the use of expensive reagents and specialized equipment.



    With the ever-increasing demand for antibiotics, there is a growing need for efficient and cost-effective methods for their synthesis.


    The chemical industry has been working to improve the synthetic routes for pristinamycin and other antibiotics in order to increase their yield and reduce the cost of production.


    One way in which this has been achieved is through the development of new and improved reagents and catalysts, which can make the reactions more efficient and stable.



    Another approach has been to use microwave irradiation to accelerate the reactions.


    Microwave irradiation has been found to increase the efficiency of a number of organic reactions, including the condensation of 3-dehydroquinatein with 7-oxo-1,4-dihydroadamantane to form pristinamycin.


    This technique has been found to reduce the reaction time and improve the yield of the desired product, making the production of antibiotics like pristinamycin more efficient and cost-effective.



    In conclusion, the synthetic routes for pristinamycin have been the subject of extensive research in the chemical industry.


    There are several methods that have been developed to produce pristinamycin, each with its own advantages and disadvantages.


    The industry continues to seek new and greener alternatives to traditional reagents and methods in order to increase the efficiency and yield of antibiotic production.


    With the growing need for antibiotics to treat bacterial infections, it is likely that these efforts will continue in the coming years as researchers work to improve the production of this important class of drugs.




    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.